SIRT1 and colorectal carcinoma: Sun et al. also reported that SIRT in colorectal cancer (CRC) could inhibit miR-15b-5p transcription and then restore ACOX1 expression, through which SIRT1 promotes fatty acid oxidation and inhibits CRC metastasis, suggesting a potential target for metastable CRC therapy [46].